(Q46301105)

21 December 2017

title

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers (English)

1 reference

21 December 2017

0 references

Yoshinari Ogawa

1

1 reference

21 December 2017

Eishu Hai

2

1 reference

21 December 2017

Kanako Matsumoto

3

1 reference

21 December 2017

Katsumi Ikeda

4

1 reference

21 December 2017

Shinya Tokunaga

5

1 reference

21 December 2017

Hisashi Nagahara

6

1 reference

21 December 2017

Katsunobu Sakurai

7

1 reference

21 December 2017

Takeshi Inoue

8

1 reference

21 December 2017

Yukio Nishiguchi

9

1 reference

21 December 2017

publication date

23 October 2008

1 reference

21 December 2017

International Journal of Clinical Oncology

published in

1 reference

21 December 2017

volume

13

1 reference

21 December 2017

page(s)

431-435

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s10147-008-0770-6

exact match

0 references

cites work

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0770-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-008-0770-6

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

21 January 2018

1 reference

12 December 2020

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

1 reference

12 December 2020

Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression

1 reference

12 December 2020

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

Prognostic markers in triple-negative breast cancer

1 reference

12 December 2020

Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.

1 reference

12 December 2020

Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines

1 reference

12 December 2020

The role of androgens in mammary carcinogenesis.

1 reference

12 December 2020

Testosterone effects on the breast: implications for testosterone therapy for women.

1 reference

12 December 2020

General rules for clinical and pathological recording of breast cancer 2005

1 reference

12 December 2020

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

1 reference

12 December 2020

Molecular genetics and epidemiology of prostate carcinoma.

1 reference

12 December 2020

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

1 reference

12 December 2020

10.1007/S10147-008-0770-6

Identifiers

DOI

1 reference

21 December 2017

release_mzavovrwfzcxfcv7fyx73tbcf4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mzavovrwfzcxfcv7fyx73tbcf4

24 November 2022

mapped directly with Wikidata item

PubMed ID

18946753

1 reference

21 December 2017